Skip to main content
Erschienen in: Archives of Women's Mental Health 3/2019

16.08.2018 | Original Article

Antidepressants in breast milk; comparative analysis of excretion ratios

verfasst von: Georgios Schoretsanitis, Marc Augustin, Helena Saßmannshausen, Cordula Franz, Gerhard Gründer, Michael Paulzen

Erschienen in: Archives of Women's Mental Health | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Despite increasing prescription rates of antidepressants in pregnant and breastfeeding women over the past decades, evidence of drug exposure for neonates through lactation is very sparse. Concentrations of three antidepressants citalopram, sertraline, and venlafaxine were measured in maternal blood and breast milk in 17 women receiving antidepressant therapy during breastfeeding period. We also computed concentration-by-dose-ratios (C/D) and milk to serum (plasma) penetration ratios (M/P). Non-parametric tests were applied. Serum concentration of citalopram and daily dosage correlated positively while daily dosage and mother milk concentration did not (rho = 0.939, p = 0.005, and rho = 0.772, p > 0.05 respectively). A significant correlation was also found between serum and milk concentrations (rho = 0.812, p = 0.05). Venlafaxine daily dosage correlated positively with the active moiety milk concentration (rho = 0.949, p = 0.014). No significant correlations were reported for sertraline. The amount of antidepressant concentrations to which neonates may be exposed, assessed as absolute infant dose (AID), was particularly low with the highest median AID being 0.16 mg/kg/day for venlafaxine. No significant difference was detected for the M/P ratios between different drugs (p > 0.05), whereas the comparison of C/D ratios revealed lower values in the sertraline group, with the highest values reported for citalopram group (p = 0.007 for serum concentrations and p = 0.008 for mother milk). Findings suggest that breastfeeding under antidepressant treatment constantly exposes children with measurable drug concentrations. As daily dosage and serum concentration of the antidepressants did not predict drug concentrations in mother milk, measuring of drug concentrations in milk helps to quantify drug exposure during breastfeeding. More data—even data of drug concentrations in breastfed children—are needed to better assess the effects of drug exposure on children’s development.
Literatur
Zurück zum Zitat Baumann P (1996) Pharmacology and pharmacokinetics of citalopram and other SSRIs. Int Clin Psychopharmacol 11(Suppl 1):5–11CrossRefPubMed Baumann P (1996) Pharmacology and pharmacokinetics of citalopram and other SSRIs. Int Clin Psychopharmacol 11(Suppl 1):5–11CrossRefPubMed
Zurück zum Zitat Begg EJ, Atkinson HC, Duffull SB (1992) Prospective evaluation of a model for the prediction of milk: plasma drug concentrations from physicochemical characteristics. Br J Clin Pharmacol 33:501–505CrossRefPubMedPubMedCentral Begg EJ, Atkinson HC, Duffull SB (1992) Prospective evaluation of a model for the prediction of milk: plasma drug concentrations from physicochemical characteristics. Br J Clin Pharmacol 33:501–505CrossRefPubMedPubMedCentral
Zurück zum Zitat Bennett PN (1996) Drugs and human lactation. Elsevier, Amsterdam Bennett PN (1996) Drugs and human lactation. Elsevier, Amsterdam
Zurück zum Zitat Berle JO, Steen VM, Aamo TO, Breilid H, Zahlsen K, Spigset O (2004) Breastfeeding during maternal antidepressant treatment with serotonin reuptake inhibitors: infant exposure, clinical symptoms, and cytochrome p450 genotypes. J Clin Psychiatry 65:1228–1234CrossRefPubMed Berle JO, Steen VM, Aamo TO, Breilid H, Zahlsen K, Spigset O (2004) Breastfeeding during maternal antidepressant treatment with serotonin reuptake inhibitors: infant exposure, clinical symptoms, and cytochrome p450 genotypes. J Clin Psychiatry 65:1228–1234CrossRefPubMed
Zurück zum Zitat Bezchlibnyk-Butler K, Aleksic I, Kennedy SH (2000) Citalopram--a review of pharmacological and clinical effects. J Psychiatry Neurosci 25:241–254PubMedPubMedCentral Bezchlibnyk-Butler K, Aleksic I, Kennedy SH (2000) Citalopram--a review of pharmacological and clinical effects. J Psychiatry Neurosci 25:241–254PubMedPubMedCentral
Zurück zum Zitat Bhatt J, Jangid A, Venkatesh G, Subbaiah G, Singh S (2005) Liquid chromatography-tandem mass spectrometry (LC-MS-MS) method for simultaneous determination of venlafaxine and its active metabolite O-desmethyl venlafaxine in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 829:75–81CrossRefPubMed Bhatt J, Jangid A, Venkatesh G, Subbaiah G, Singh S (2005) Liquid chromatography-tandem mass spectrometry (LC-MS-MS) method for simultaneous determination of venlafaxine and its active metabolite O-desmethyl venlafaxine in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 829:75–81CrossRefPubMed
Zurück zum Zitat Burt VK, Suri R, Altshuler L, Stowe Z, Hendrick VC, Muntean E (2001) The use of psychotropic medications during breast-feeding. Am J Psychiatry 158:1001–1009CrossRefPubMed Burt VK, Suri R, Altshuler L, Stowe Z, Hendrick VC, Muntean E (2001) The use of psychotropic medications during breast-feeding. Am J Psychiatry 158:1001–1009CrossRefPubMed
Zurück zum Zitat Cohen LS, Viguera AC, Bouffard SM, Nonacs RM, Morabito C, Collins MH et al (2001) Venlafaxine in the treatment of postpartum depression. J Clin Psychiatry 62:592–596CrossRefPubMed Cohen LS, Viguera AC, Bouffard SM, Nonacs RM, Morabito C, Collins MH et al (2001) Venlafaxine in the treatment of postpartum depression. J Clin Psychiatry 62:592–596CrossRefPubMed
Zurück zum Zitat Devane CL, Liston HL, Markowitz JS (2002) Clinical pharmacokinetics of sertraline. Clin Pharmacokinet 41:1247–1266CrossRefPubMed Devane CL, Liston HL, Markowitz JS (2002) Clinical pharmacokinetics of sertraline. Clin Pharmacokinet 41:1247–1266CrossRefPubMed
Zurück zum Zitat Eberhard-Gran M, Eskild A, Opjordsmoen S (2006) Use of psychotropic medications in treating mood disorders during lactation: practical recommendations. CNS Drugs 20:187–198CrossRefPubMed Eberhard-Gran M, Eskild A, Opjordsmoen S (2006) Use of psychotropic medications in treating mood disorders during lactation: practical recommendations. CNS Drugs 20:187–198CrossRefPubMed
Zurück zum Zitat Eke AC, Saccone G, Berghella V (2016) Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and risk of preterm birth: a systematic review and meta-analysis. BJOG 123(12):1900–1907 Eke AC, Saccone G, Berghella V (2016) Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and risk of preterm birth: a systematic review and meta-analysis. BJOG 123(12):1900–1907
Zurück zum Zitat Franssen EJ, Meijs V, Ettaher F, Valerio PG, Keessen M, Lameijer W (2006) Citalopram serum and milk levels in mother and infant during lactation. Ther Drug Monit 28:2–4CrossRefPubMed Franssen EJ, Meijs V, Ettaher F, Valerio PG, Keessen M, Lameijer W (2006) Citalopram serum and milk levels in mother and infant during lactation. Ther Drug Monit 28:2–4CrossRefPubMed
Zurück zum Zitat Gentile S (2005) The safety of newer antidepressants in pregnancy and breastfeeding. Drug Saf 28(2):137–52 Gentile S (2005) The safety of newer antidepressants in pregnancy and breastfeeding. Drug Saf 28(2):137–52
Zurück zum Zitat Gentile S (2007) Use of contemporary antidepressants during breastfeeding: a proposal for a specific safety index. Drug Saf 30:107–121CrossRefPubMed Gentile S (2007) Use of contemporary antidepressants during breastfeeding: a proposal for a specific safety index. Drug Saf 30:107–121CrossRefPubMed
Zurück zum Zitat Heikkinen T, Ekblad U, Kero P, Ekblad S, Laine K (2002) Citalopram in pregnancy and lactation. Clin Pharmacol Ther 72:184–191CrossRefPubMed Heikkinen T, Ekblad U, Kero P, Ekblad S, Laine K (2002) Citalopram in pregnancy and lactation. Clin Pharmacol Ther 72:184–191CrossRefPubMed
Zurück zum Zitat Hendrick V, Smith LM, Hwang S, Altshuler LL, Haynes D (2003) Weight gain in breastfed infants of mothers taking antidepressant medications. J Clin Psychiatry 64:410–412CrossRefPubMed Hendrick V, Smith LM, Hwang S, Altshuler LL, Haynes D (2003) Weight gain in breastfed infants of mothers taking antidepressant medications. J Clin Psychiatry 64:410–412CrossRefPubMed
Zurück zum Zitat Hiemke, C., Bergemann, N., Clement, H. W., Conca, A., Deckert, J., Domschke, K., et al. 2017. Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017. Pharmacopsychiatry Hiemke, C., Bergemann, N., Clement, H. W., Conca, A., Deckert, J., Domschke, K., et al. 2017. Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017. Pharmacopsychiatry
Zurück zum Zitat Hiemke C, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K et al (2018) Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017. Pharmacopsychiatry 51(1-02):e1PubMed Hiemke C, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K et al (2018) Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017. Pharmacopsychiatry 51(1-02):e1PubMed
Zurück zum Zitat Ilett KF, Hackett LP, Dusci LJ, Roberts MJ, Kristensen JH, Paech M et al (1998) Distribution and excretion of venlafaxine and O-desmethylvenlafaxine in human milk. Br J Clin Pharmacol 45:459–462CrossRefPubMedPubMedCentral Ilett KF, Hackett LP, Dusci LJ, Roberts MJ, Kristensen JH, Paech M et al (1998) Distribution and excretion of venlafaxine and O-desmethylvenlafaxine in human milk. Br J Clin Pharmacol 45:459–462CrossRefPubMedPubMedCentral
Zurück zum Zitat Jensen PN, Olesen OV, Bertelsen A, Linnet K (1997) Citalopram and desmethylcitalopram concentrations in breast milk and in serum of mother and infant. Ther Drug Monit 19:236–239CrossRefPubMed Jensen PN, Olesen OV, Bertelsen A, Linnet K (1997) Citalopram and desmethylcitalopram concentrations in breast milk and in serum of mother and infant. Ther Drug Monit 19:236–239CrossRefPubMed
Zurück zum Zitat Jimenez-Solem E (2014) Exposure to antidepressants during pregnancy--prevalences and outcomes. Dan Med J 61:B4916PubMed Jimenez-Solem E (2014) Exposure to antidepressants during pregnancy--prevalences and outcomes. Dan Med J 61:B4916PubMed
Zurück zum Zitat Klamerus KJ, Maloney K, Rudolph RL, Sisenwine SF, Jusko WJ, Chiang ST (1992) Introduction of a composite parameter to the pharmacokinetics of venlafaxine and its active O-desmethyl metabolite. J Clin Pharmacol 32:716–724CrossRefPubMed Klamerus KJ, Maloney K, Rudolph RL, Sisenwine SF, Jusko WJ, Chiang ST (1992) Introduction of a composite parameter to the pharmacokinetics of venlafaxine and its active O-desmethyl metabolite. J Clin Pharmacol 32:716–724CrossRefPubMed
Zurück zum Zitat Kristensen JH, Ilett KF, Dusci LJ, Hackett LP, Yapp P, Wojnar-Horton RE et al (1998) Distribution and excretion of sertraline and N-desmethylsertraline in human milk. Br J Clin Pharmacol 45:453–457CrossRefPubMedPubMedCentral Kristensen JH, Ilett KF, Dusci LJ, Hackett LP, Yapp P, Wojnar-Horton RE et al (1998) Distribution and excretion of sertraline and N-desmethylsertraline in human milk. Br J Clin Pharmacol 45:453–457CrossRefPubMedPubMedCentral
Zurück zum Zitat Laine K, Heikkinen T, Ekblad U, Kero P (2003) Effects of exposure to selective serotonin reuptakers inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations. Arch Gen Psychiatry 60(7):720–726 Laine K, Heikkinen T, Ekblad U, Kero P (2003) Effects of exposure to selective serotonin reuptakers inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations. Arch Gen Psychiatry 60(7):720–726
Zurück zum Zitat Lanza Di Scalea T, Wisner KL (2009) Antidepressant medication use during breastfeeding. Clin Obstet Gynecol 52:483–497CrossRefPubMed Lanza Di Scalea T, Wisner KL (2009) Antidepressant medication use during breastfeeding. Clin Obstet Gynecol 52:483–497CrossRefPubMed
Zurück zum Zitat Lee A, Woo J, Ito S (2004) Frequency of infant adverse events that are associated with citalopram use during breast-feeding. Am J Obstet Gynecol 190:218–221CrossRefPubMed Lee A, Woo J, Ito S (2004) Frequency of infant adverse events that are associated with citalopram use during breast-feeding. Am J Obstet Gynecol 190:218–221CrossRefPubMed
Zurück zum Zitat Misri S, Corral M, Wardrop AA, Kendrick K (2006) Quetiapine augmentation in lactation: a series of case reports. J Clin Psychopharmacol 26:508–511CrossRefPubMed Misri S, Corral M, Wardrop AA, Kendrick K (2006) Quetiapine augmentation in lactation: a series of case reports. J Clin Psychopharmacol 26:508–511CrossRefPubMed
Zurück zum Zitat Misri S, Kostaras X (2002) Benefits and risks to mother and infant of drug treatment for postnatal depression. Drug Saf 25:903–911CrossRefPubMed Misri S, Kostaras X (2002) Benefits and risks to mother and infant of drug treatment for postnatal depression. Drug Saf 25:903–911CrossRefPubMed
Zurück zum Zitat Müller MJ, Preuss C, Paul T, Streit F, Brandhorst G, Seeliger S (2013) Serotonergic overstimulation in a preterm infant after sertraline intake via breastmilk. Breastfeed Med 8:327–329CrossRefPubMed Müller MJ, Preuss C, Paul T, Streit F, Brandhorst G, Seeliger S (2013) Serotonergic overstimulation in a preterm infant after sertraline intake via breastmilk. Breastfeed Med 8:327–329CrossRefPubMed
Zurück zum Zitat Nulman I, Ito S, Koren G (2003) Handbook of female Psychophamacology. Taylor & Francis, London Nulman I, Ito S, Koren G (2003) Handbook of female Psychophamacology. Taylor & Francis, London
Zurück zum Zitat Ornoy A, Koren G (2017) Selective serotonin reuptake inhibitors during pregnancy: do we have now more definite answers related to prenatal exposure? Birth Defects Res 109(12):898–908 Ornoy A, Koren G (2017) Selective serotonin reuptake inhibitors during pregnancy: do we have now more definite answers related to prenatal exposure? Birth Defects Res 109(12):898–908
Zurück zum Zitat Paulzen M, Goecke TW, Stickeler E, Grunder G, Schoretsanitis G (2017a) Sertraline in pregnancy - therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood. J Affect Disord 212:1–6CrossRefPubMed Paulzen M, Goecke TW, Stickeler E, Grunder G, Schoretsanitis G (2017a) Sertraline in pregnancy - therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood. J Affect Disord 212:1–6CrossRefPubMed
Zurück zum Zitat Paulzen M, Goecke TW, Stingl JC, Janssen G, Stickeler E, Gründer G et al (2017b) Pregnancy exposure to citalopram - therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood. Prog Neuro-Psychopharmacol Biol Psychiatry 79:213–219CrossRef Paulzen M, Goecke TW, Stingl JC, Janssen G, Stickeler E, Gründer G et al (2017b) Pregnancy exposure to citalopram - therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood. Prog Neuro-Psychopharmacol Biol Psychiatry 79:213–219CrossRef
Zurück zum Zitat Payne JL (2007) Antidepressant use in the postpartum period: practical considerations. Am J Psychiatry 164:1329–1332CrossRefPubMed Payne JL (2007) Antidepressant use in the postpartum period: practical considerations. Am J Psychiatry 164:1329–1332CrossRefPubMed
Zurück zum Zitat Pearlstein TB, Zlotnick C, Battle CL, Stuart S, O'hara MW, Price AB et al (2006) Patient choice of treatment for postpartum depression: a pilot study. Arch Womens Ment Health 9:303–308CrossRefPubMed Pearlstein TB, Zlotnick C, Battle CL, Stuart S, O'hara MW, Price AB et al (2006) Patient choice of treatment for postpartum depression: a pilot study. Arch Womens Ment Health 9:303–308CrossRefPubMed
Zurück zum Zitat Preskorn SH (1993) Pharmacokinetics of antidepressants: why and how they are relevant to treatment. J Clin Psychiatry 54(Suppl):14–34 discussion 55-6PubMed Preskorn SH (1993) Pharmacokinetics of antidepressants: why and how they are relevant to treatment. J Clin Psychiatry 54(Suppl):14–34 discussion 55-6PubMed
Zurück zum Zitat Preskorn SH (1996) Clinical pharmacology of SSRI's. Okla, Professional Communications, Inc., Caddo Preskorn SH (1996) Clinical pharmacology of SSRI's. Okla, Professional Communications, Inc., Caddo
Zurück zum Zitat Reis M, Aberg-Wistedt A, Agren H, Hoglund P, Akerblad AC, Bengtsson F (2004) Serum disposition of sertraline, N-desmethylsertraline and paroxetine: a pharmacokinetic evaluation of repeated drug concentration measurements during 6 months of treatment for major depression. Hum Psychopharmacol 19:283–291CrossRefPubMed Reis M, Aberg-Wistedt A, Agren H, Hoglund P, Akerblad AC, Bengtsson F (2004) Serum disposition of sertraline, N-desmethylsertraline and paroxetine: a pharmacokinetic evaluation of repeated drug concentration measurements during 6 months of treatment for major depression. Hum Psychopharmacol 19:283–291CrossRefPubMed
Zurück zum Zitat Schmidt K, Olesen OV, Jensen PN (2000) Citalopram and breast-feeding: serum concentration and side effects in the infant. Biol Psychiatry 47:164–165CrossRefPubMed Schmidt K, Olesen OV, Jensen PN (2000) Citalopram and breast-feeding: serum concentration and side effects in the infant. Biol Psychiatry 47:164–165CrossRefPubMed
Zurück zum Zitat Shams ME, Arneth B, Hiemke C, Dragicevic A, Muller MJ, Kaiser R et al (2006) CYP2D6 polymorphism and clinical effect of the antidepressant venlafaxine. J Clin Pharm Ther 31:493–502CrossRef Shams ME, Arneth B, Hiemke C, Dragicevic A, Muller MJ, Kaiser R et al (2006) CYP2D6 polymorphism and clinical effect of the antidepressant venlafaxine. J Clin Pharm Ther 31:493–502CrossRef
Zurück zum Zitat Stowe ZN, Owens MJ, Landry JC, Kilts CD, Ely T, Llewellyn A et al (1997) Sertraline and desmethylsertraline in human breast milk and nursing infants. Am J Psychiatry 154:1255–1260CrossRefPubMed Stowe ZN, Owens MJ, Landry JC, Kilts CD, Ely T, Llewellyn A et al (1997) Sertraline and desmethylsertraline in human breast milk and nursing infants. Am J Psychiatry 154:1255–1260CrossRefPubMed
Zurück zum Zitat Troy SM, Parker VP, Hicks DR, Pollack GM, Chiang ST (1997) Pharmacokinetics and effect of food on the bioavailability of orally administered venlafaxine. J Clin Pharmacol 37:954–961CrossRefPubMed Troy SM, Parker VP, Hicks DR, Pollack GM, Chiang ST (1997) Pharmacokinetics and effect of food on the bioavailability of orally administered venlafaxine. J Clin Pharmacol 37:954–961CrossRefPubMed
Zurück zum Zitat Weissman AM, Levy BT, Hartz AJ, Bentler S, Donohue M, Ellingrod VL et al (2004) Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants. Am J Psychiatry 161:1066–1078CrossRef Weissman AM, Levy BT, Hartz AJ, Bentler S, Donohue M, Ellingrod VL et al (2004) Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants. Am J Psychiatry 161:1066–1078CrossRef
Zurück zum Zitat Whitby DH, Smith KM (2005) The use of tricyclic antidepressants and selective serotonin reuptake inhibitors in women who are breastfeeding. Pharmacotherapy 25:411–425CrossRefPubMed Whitby DH, Smith KM (2005) The use of tricyclic antidepressants and selective serotonin reuptake inhibitors in women who are breastfeeding. Pharmacotherapy 25:411–425CrossRefPubMed
Zurück zum Zitat Wisner KL, Hanusa BH, Perel JM, Peindl KS, Piontek CM, Sit DK et al (2006) Postpartum depression: a randomized trial of sertraline versus nortriptyline. J Clin Psychopharmacol 26:353–360CrossRefPubMed Wisner KL, Hanusa BH, Perel JM, Peindl KS, Piontek CM, Sit DK et al (2006) Postpartum depression: a randomized trial of sertraline versus nortriptyline. J Clin Psychopharmacol 26:353–360CrossRefPubMed
Metadaten
Titel
Antidepressants in breast milk; comparative analysis of excretion ratios
verfasst von
Georgios Schoretsanitis
Marc Augustin
Helena Saßmannshausen
Cordula Franz
Gerhard Gründer
Michael Paulzen
Publikationsdatum
16.08.2018
Verlag
Springer Vienna
Erschienen in
Archives of Women's Mental Health / Ausgabe 3/2019
Print ISSN: 1434-1816
Elektronische ISSN: 1435-1102
DOI
https://doi.org/10.1007/s00737-018-0905-3

Weitere Artikel der Ausgabe 3/2019

Archives of Women's Mental Health 3/2019 Zur Ausgabe

Neu in den Fachgebieten Neurologie und Psychiatrie